Kainova Therapeutics expands phase I/II trial of antibody drug
April 7, 2026Research and Development
Kainova Therapeutics has announced that the first patient in the European expansion of its DOMISOL phase I/II clinical trial evaluating …
Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086
April 7, 2026Research and Development
Eisai is to begin enrolling participants in its phase 2 study, Study 202, in patients with narcolepsy. The company registered …
Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer
April 2, 2026Faron Pharmaceuticals
Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Heikki Jouttijärvi as Chief Technical Officer (CTO). Jouttijärvi brings decades of experience …
Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London
April 1, 2026Conferencing, Events & Incentives Cambridge, Cambridge Wide Open Week, London, Oxford
Cambridge Wide Open Week (CWOW) returns from 11-19 June 2026, sharing the spirit and buzz of the week-long, interactive festival …
Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO
April 1, 2026Doccla
Doccla, an AI-powered Proactive Care company, has appointed Michael Macdonnell as Chief Strategy & Growth Officer, and Deputy CEO. As …
Bramacare launches new AI platform to improve eating disorder care
March 31, 2026Market & Product Development AI, Bramacare, eating disorders
Bramacare has launched an AI-enabled platform designed to aid eating disorder and rehabilitation services, the first of its kind in …
Doccla appoints Jonathan Serjeant as Chief Medical Officer
March 31, 2026Doccla
Doccla, an AI-powered Proactive Care company, has appointed Jonathan Serjeant as Chief Medical Officer (CMO). Serjeant brings 25 years of …
SAH Diagnostics opens new diagnostics centre in Bristol
March 30, 2026Health check service Bristol, Bristol Community Diagnostics Hub, SAH Diagnostics
SAH Diagnostics has opened a new privately run diagnostics centre in Bradley Stoke, Bristol, aiming to speed up cancer treatments …
Abselion appoints Dale Gordon as Chair
March 30, 2026Abselion
Abselion has appointed Dale Gordon as Chair of the Board of Directors. Bringing over 30 years of experience to the …
Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month
March 26, 2026Patient Awareness Programmes Bowel Cancer Awareness Month, Stage4You, mental health
Stage4You, a campaign funded and developed by Takeda UK and supported by Bowel Cancer UK, is encouraging patients with stage …
Scotland starts newborn screening for SMA
March 26, 2026Novartis, Scotland, spinal muscular atrophy (SMA)
As part of a two-year evaluation funded by the Scottish government and Novartis, Scotland will screen newborn babies for Spinal …
Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board
March 25, 2026Secarna Pharmaceuticals
Secarna Pharmaceuticals has appointed Jens Holstein and Richard Mark Engelhard to its new Advisory Board. As part of the board, …
Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory
March 25, 2026Research and Development AI, NVIDIA, Roche
Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance graphics processing units (GPUs) across …
ReproNovo appoints Mark Altmeyer as Chairman of the Board
March 24, 2026ReproNovo
ReproNovo has appointed Mark Altmeyer as Chairman of the Board of Directors. Bringing over 35 years of experience to the …
EndoCyclic New Drug application approved by US FDA for endometriosis treatment
March 24, 2026Research and Development EndoCyclic Therapeutics, FDA, endometriosis
EndoCyclic Therapeutics’ Investigational New Drug (IND) application for its lead programme, ENDO-205, has been approved by the US FDA. With …
Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer
March 23, 2026Mestag Therapeutics
Mestag has appointed Lindsey Rolfe as Chief Medical Officer (CMO) and Pascal Merchiers as Chief Development Officer (CDO). Bringing over …
Outrun Therapeutics announces its lead programme for HPV positive cancer
March 23, 2026Research and Development HPV, Oncology, Outrun Therapeutics
Outrun Therapeutics has selected an E6AP inhibitor strategy as its lead programme for treating HPV positive head and neck cancer. …
IsomAb appoints Philip Brainin as CEO
March 19, 2026IsomAb
IsomAb has appointed Dr Philip Brainin as CEO and member of the Board of Directors. In this new role, Dr …
Naobios partners with SGS to manufacture RSV challenge agent
March 19, 2026Manufacturing and Production Naobios, RSV, SGS
Contract Development and Manufacturing Organisation (CDMO) Naobios has partnered with SGS, a testing, inspection and certification company, to manufacture a …
Qlaris Bio appoints Fred Guerard as President and CEO
March 18, 2026Qlaris Bio
Qlaris Bio, a clinical-stage biotechnology company, has appointed Fred Guerard as president and CEO. Guerard will also join the Board …
Latest content
FibroFind appoints Lee Borthwick as CEO
